Pictet & Cie Europe Sa Holding in Lilly Eli & Co (LLY) Decreased by $9.36 Million; Graham Capital Management LP Has Decreased Its Lee Enterprises (LEE) Position by $900,000 as Share Price Declined

Eli Lilly and Company (NYSE:LLY) Logo

Pictet & Cie Europe Sa decreased its stake in Lilly Eli & Co (LLY) by 97.68% based on its latest 2018Q3 regulatory filing with the SEC. Pictet & Cie Europe Sa sold 87,520 shares as the company’s stock rose 7.21% while stock markets declined. The institutional investor held 2,075 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $223,000, down from 89,595 at the end of the previous reported quarter. Pictet & Cie Europe Sa who had been investing in Lilly Eli & Co for a number of months, seems to be less bullish one the $120.64 billion market cap company. The stock increased 1.79% or $2.1 during the last trading session, reaching $119.6. About 16.20M shares traded or 213.46% up from the average. Eli Lilly and Company (NYSE:LLY) has risen 32.86% since February 10, 2018 and is uptrending. It has outperformed by 32.86% the S&P500. Some Historical LLY News: 27/03/2018 – Global Human Growth Hormone (hGH) Market Analysis & Outlook 2018-2022 with Profiles of Novartis, Pfizer, Eli Lilly and Co and Novo Nordisk – ResearchAndMarkets.com; 04/04/2018 – TERNS PHARMACEUTICALS INC – DEVELOPMENT OF CLINICAL PROGRAMS WILL FOCUS ON REGULATORY APPROVAL IN CHINA AND ADDITIONAL GLOBAL MARKETS; 23/04/2018 – FDA ADVISORY COMMITTEE RECOMMENDS APPROVAL OF BARICITINIB 2MG,; 09/03/2018 – Maura Dickler, M.D., to become Vice President of Late Phase Development at Lilly Oncology; 15/04/2018 – Updated Overall Survival Data for LYNPARZA® (olaparib) in gBRCA-mutated HER2-Negative Metastatic Breast Cancer Presented at; 03/05/2018 – European Medicines Agency Validates Bristol-Myers Squibb’s Type Il Variation Application for Opdivo Plus Yervoy Combination for Treatment of First-Line Metastatic Non-Small Cell Lung Cancer (NSCLC); 24/04/2018 – ELI LILLY AND CO CEO SAYS PLANS TO SHARE FINDINGS OF STRATEGIC REVIEW OF ANIMAL HEALTH BUSINESS IN JULY; 12/04/2018 – JNJ: INVOKANA IMPROVED RENAL OUTCOMES IN TYPE 2 DIABETES; 09/03/2018 – MAURA DICKLER NAMED VP LATE PHASE DEVELOPMENT LILLY ONCOLOGY; 15/05/2018 – Lilly Presenting at Bank of America Conference Tomorrow

Graham Capital Management Lp decreased its stake in Lee Enterprises Inc (LEE) by 49.12% based on its latest 2018Q3 regulatory filing with the SEC. Graham Capital Management Lp sold 450,000 shares as the company’s stock declined 20.00% with the market. The hedge fund held 466,128 shares of the consumer services company at the end of 2018Q3, valued at $1.24M, down from 916,128 at the end of the previous reported quarter. Graham Capital Management Lp who had been investing in Lee Enterprises Inc for a number of months, seems to be less bullish one the $154.61 million market cap company. The stock decreased 0.74% or $0.02 during the last trading session, reaching $2.68. About 55,088 shares traded. Lee Enterprises, Incorporated (NYSE:LEE) has declined 7.83% since February 10, 2018 and is downtrending. It has underperformed by 7.83% the S&P500. Some Historical LEE News: 03/05/2018 – Lee Enterprises 2Q Rev $127.8M; 03/05/2018 – Lee Enterprises 2Q Net $2.53M; 03/05/2018 – Lee Enterprises 2Q Digital Revenue $26.7M, Up 3.6%; 16/03/2018 E.W. Scripps activist campaign could add independent pressure on family –; 20/04/2018 – DJ Lee Enterprises Incorporated, Inst Holders, 1Q 2018 (LEE); 03/05/2018 – Lee Enterprises 2Q Subscription Rev Increased 2.1%; 03/05/2018 – Lee Enterprises 2Q EPS 4c; 03/05/2018 – LEE ENTERPRISES – OPERATING REVENUE FOR THE 13 WEEKS ENDED MARCH 25, 2018 TOTALED $127.8 MILLION, A DECREASE OF 4.2%; 26/04/2018 – Lee Enterprises plans quarterly call and webcast May 3, 2018

Graham Capital Management Lp, which manages about $16.17 billion and $4.81 billion US Long portfolio, upped its stake in Adobe Sys Inc (NASDAQ:ADBE) by 8,856 shares to 13,073 shares, valued at $3.53 million in 2018Q3, according to the filing. It also increased its holding in Jpmorgan Chase & Co (NYSE:JPM) by 20,970 shares in the quarter, for a total of 30,005 shares, and has risen its stake in Visa Inc (NYSE:V).

More notable recent Lee Enterprises, Incorporated (NYSE:LEE) news were published by: Seekingalpha.com which released: “Chinese internet stocks slide on ad challenges – Seeking Alpha” on January 22, 2019, also Bizjournals.com with their article: “Which banks should worry the most with JP Morgan’s presence in the Triangle? – Triangle Business Journal” published on January 18, 2019, Bizjournals.com published: “Post-Dispatch offers employees another round of buyouts – St. Louis Business Journal” on January 22, 2019. More interesting news about Lee Enterprises, Incorporated (NYSE:LEE) were released by: Businesswire.com and their article: “Investor Group Led by CC Capital, Cannae Holdings, Bilcar, Black Knight and Thomas H. Lee Partners Completes Acquisition of Dun & Bradstreet – Business Wire” published on February 08, 2019 as well as Fool.com‘s news article titled: “Wall Street Has Given Up on These 3 Stocks, and That’s a Huge Mistake – The Motley Fool” with publication date: February 09, 2019.

Among 25 analysts covering Eli Lilly and Company (NYSE:LLY), 13 have Buy rating, 0 Sell and 12 Hold. Therefore 52% are positive. Eli Lilly and Company had 124 analyst reports since July 23, 2015 according to SRatingsIntel. Credit Suisse upgraded it to “Outperform” rating and $105 target in Friday, October 9 report. The rating was downgraded by Berenberg to “Hold” on Wednesday, July 25. The firm has “Buy” rating by Piper Jaffray given on Friday, September 8. The firm has “Neutral” rating given on Wednesday, July 25 by Bank of America. As per Thursday, February 1, the company rating was maintained by Bank of America. The firm has “Sell” rating by BMO Capital Markets given on Tuesday, July 25. The company was maintained on Monday, May 2 by Leerink Swann. As per Friday, April 7, the company rating was maintained by Citigroup. Atlantic Securities downgraded the stock to “Neutral” rating in Friday, November 25 report. As per Tuesday, April 11, the company rating was maintained by Jefferies.

More notable recent Eli Lilly and Company (NYSE:LLY) news were published by: Seekingalpha.com which released: “Eli Lilly Surges On Pipeline News: Analysis And Trading Thoughts – Seeking Alpha” on October 08, 2018, also Fool.com with their article: “Stock Market Power Rankings: Facebook Cashes In – The Motley Fool” published on January 27, 2019, Investorplace.com published: “Trade of the Day: Eli Lilly (LLY) – Investorplace.com” on September 27, 2018. More interesting news about Eli Lilly and Company (NYSE:LLY) were released by: Seekingalpha.com and their article: “Lilly bails on BTK inhibitor LY3337641 – Seeking Alpha” published on February 06, 2019 as well as Seekingalpha.com‘s news article titled: “Merger Arbitrage Mondays – February 4, 2019 – Seeking Alpha” with publication date: February 04, 2019.

Since August 15, 2018, it had 0 buys, and 27 selling transactions for $321.50 million activity. Another trade for 6,000 shares valued at $637,830 was sold by Zulueta Alfonso G. Shares for $2.82 million were sold by O’Neill Myles. The insider Zakrowski Donald A sold $63,342.

Investors sentiment increased to 0.98 in 2018 Q3. Its up 0.14, from 0.84 in 2018Q2. It increased, as 37 investors sold LLY shares while 399 reduced holdings. 141 funds opened positions while 286 raised stakes. 794.28 million shares or 1.80% less from 808.82 million shares in 2018Q2 were reported. Cornercap Investment Counsel Inc accumulated 48,050 shares or 0.67% of the stock. Eaton Vance Mngmt reported 0.76% stake. Sadoff Investment Mgmt Ltd Limited Liability Company owns 8,390 shares. Sarasin & Partners Llp owns 33,301 shares for 0.07% of their portfolio. Winslow Evans & Crocker accumulated 8,296 shares or 0.27% of the stock. Flippin Bruce And Porter reported 101,889 shares. Bnp Paribas Arbitrage Sa has 2.32 million shares for 0% of their portfolio. Stewart And Patten Ltd Liability Company has invested 0.18% in Eli Lilly and Company (NYSE:LLY). 53.60M are owned by Wellington Mgmt Grp Limited Liability Partnership. Louisiana State Employees Retirement System reported 0.26% in Eli Lilly and Company (NYSE:LLY). Columbia Asset Mgmt holds 0.14% in Eli Lilly and Company (NYSE:LLY) or 4,838 shares. San Francisco Sentry Inv (Ca), a California-based fund reported 2,061 shares. Knott David M holds 300 shares or 0.01% of its portfolio. Illinois-based First Midwest Savings Bank Tru Division has invested 0.71% in Eli Lilly and Company (NYSE:LLY). Strs Ohio holds 511,341 shares.

Eli Lilly and Company (NYSE:LLY) Institutional Positions Chart